Hedge Funds Never Been Less Bullish On Nabriva Therapeutics plc (NBRV)
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Nabriva Therapeutics Plc (NBRV)
$1.42 +0.01 (+0.71%) Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.57 | 100,000 | Officer, Director | 325,879 | 2021-12-28 | Filing | |
| $0.59 | 7,000 | Officer | 7,000 | 2021-12-27 | Filing | |
| $1.13 | 50,000 | Officer, Director | 226,875 | 2021-09-14 | Filing | |
| $2.03 | 10,177 | Director | 208,750 | 2019-08-30 | Filing | |
| $1.79 | 50,000 | Officer, Director | 117,489 | 2019-08-27 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.19 | 11,341 | Director | 10,384 | 2022-08-02 | Filing | |
| $0.19 | 5,339 | Director | 36,523 | 2022-08-02 | Filing | |
| $0.19 | 7,826 | Director | 11,447 | 2022-08-02 | Filing | |
| $0.19 | 10,297 | Director | 7,203 | 2022-08-02 | Filing | |
| $0.18 | 8,496 | Director | 15,277 | 2022-08-01 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% |
News See All
Is NBRV A Good Stock To Buy Now?
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios.
Is Nabriva Therapeutics plc (NBRV) A Good Stock To Buy?
We at Insider Monkey have gone over 821 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of March...
Smart Money Is Buying Nabriva Therapeutics plc (NBRV)
Is Nabriva Therapeutics plc (NASDAQ:NBRV) a good bet right now? We like to analyze hedge fund sentiment before conducting days of in-depth research.
Hedge Funds Have Never Been More Bullish On Nabriva Therapeutics plc (NBRV)
The first quarter was a breeze as Powell pivoted, and China seemed eager to reach a deal with Trump.
3 Small-Cap Biotech Stocks That Could be Poised to Explode
With the threat of severe drug pricing regulations behind it for now, the biotech sector has launched a rally in recent days, with the iShares NASDAQ Biotechnology Index (ETF) (NASDAQ:IBB) gaining over...
13D Filing: OrbiMed Advisors and Nabriva Therapeutics PLC - ADR (NBRV)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of § 240.13d-1(e), 240.13d...
These Two Healthcare Stocks Receive A Vote Of Confidence From Elite Hedge Fund Managers
As U.S equities have plummeted on global-growth worries, confident hedge funds and other investors have started piling up more shares of companies that are trading on the cheap.
Billionaire Hedge Funds
